The Readout Loud
Een podcast door STAT - Donderdagen
350 Afleveringen
-
228: A surprise success in Alzheimer's and how FDA history seeded modern controversy
Gepubliceerd: 29-9-2022 -
227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0
Gepubliceerd: 22-9-2022 -
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
Gepubliceerd: 15-9-2022 -
225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
Gepubliceerd: 8-9-2022 -
224: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
Gepubliceerd: 1-9-2022 -
223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO
Gepubliceerd: 25-8-2022 -
222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment
Gepubliceerd: 18-8-2022 -
221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing
Gepubliceerd: 11-8-2022 -
220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble
Gepubliceerd: 4-8-2022 -
219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data
Gepubliceerd: 28-7-2022 -
218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search
Gepubliceerd: 21-7-2022 -
217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'
Gepubliceerd: 14-7-2022 -
216: VC malaise, FDA confusion, & yet another Alzheimer's debate
Gepubliceerd: 7-7-2022 -
215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
Gepubliceerd: 30-6-2022 -
214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
Gepubliceerd: 23-6-2022 -
213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback
Gepubliceerd: 16-6-2022 -
212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Gepubliceerd: 9-6-2022 -
211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
Gepubliceerd: 2-6-2022 -
210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Gepubliceerd: 26-5-2022 -
Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
Gepubliceerd: 19-5-2022
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.